These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 31371804)
1. Comparing human iPSC-cardiomyocytes versus HEK293T cells unveils disease-causing effects of Brugada mutation A735V of Na de la Roche J; Angsutararux P; Kempf H; Janan M; Bolesani E; Thiemann S; Wojciechowski D; Coffee M; Franke A; Schwanke K; Leffler A; Luanpitpong S; Issaragrisil S; Fischer M; Zweigerdt R Sci Rep; 2019 Aug; 9(1):11173. PubMed ID: 31371804 [TBL] [Abstract][Full Text] [Related]
2. A cellular model of Brugada syndrome with SCN10A variants using human-induced pluripotent stem cell-derived cardiomyocytes. El-Battrawy I; Albers S; Cyganek L; Zhao Z; Lan H; Li X; Xu Q; Kleinsorge M; Huang M; Liao Z; Zhong R; Rudic B; Müller J; Dinkel H; Lang S; Diecke S; Zimmermann WH; Utikal J; Wieland T; Borggrefe M; Zhou X; Akin I Europace; 2019 Sep; 21(9):1410-1421. PubMed ID: 31106349 [TBL] [Abstract][Full Text] [Related]
3. hiPSC-derived cardiomyocytes from Brugada Syndrome patients without identified mutations do not exhibit clear cellular electrophysiological abnormalities. Veerman CC; Mengarelli I; Guan K; Stauske M; Barc J; Tan HL; Wilde AA; Verkerk AO; Bezzina CR Sci Rep; 2016 Aug; 6():30967. PubMed ID: 27485484 [TBL] [Abstract][Full Text] [Related]
4. Patient-Specific and Genome-Edited Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Brugada Syndrome. Liang P; Sallam K; Wu H; Li Y; Itzhaki I; Garg P; Zhang Y; Vermglinchan V; Lan F; Gu M; Gong T; Zhuge Y; He C; Ebert AD; Sanchez-Freire V; Churko J; Hu S; Sharma A; Lam CK; Scheinman MM; Bers DM; Wu JC J Am Coll Cardiol; 2016 Nov; 68(19):2086-2096. PubMed ID: 27810048 [TBL] [Abstract][Full Text] [Related]
5. Maturation of hiPSC-derived cardiomyocytes promotes adult alternative splicing of SCN5A and reveals changes in sodium current associated with cardiac arrhythmia. Campostrini G; Kosmidis G; Ward-van Oostwaard D; Davis RP; Yiangou L; Ottaviani D; Veerman CC; Mei H; Orlova VV; Wilde AAM; Bezzina CR; Verkerk AO; Mummery CL; Bellin M Cardiovasc Res; 2023 Mar; 119(1):167-182. PubMed ID: 35394010 [TBL] [Abstract][Full Text] [Related]
6. Anti-arrhythmic potential of the late sodium current inhibitor GS-458967 in murine Scn5a-1798insD+/- and human SCN5A-1795insD+/- iPSC-derived cardiomyocytes. Portero V; Casini S; Hoekstra M; Verkerk AO; Mengarelli I; Belardinelli L; Rajamani S; Wilde AAM; Bezzina CR; Veldkamp MW; Remme CA Cardiovasc Res; 2017 Jun; 113(7):829-838. PubMed ID: 28430892 [TBL] [Abstract][Full Text] [Related]
7. Loss of sodium current caused by a Brugada syndrome-associated variant is determined by patient-specific genetic background. Martínez-Moreno R; Carreras D; Sarquella-Brugada G; Pérez GJ; Selga E; Scornik FS; Brugada R Heart Rhythm; 2024 Mar; 21(3):331-339. PubMed ID: 38008367 [TBL] [Abstract][Full Text] [Related]
8. Patient-specific iPSC-derived cardiomyocytes reveal aberrant activation of Wnt/β-catenin signaling in SCN5A-related Brugada syndrome. Cai D; Wang X; Sun Y; Fan H; Zhou J; Yang Z; Qiu H; Wang J; Su J; Gong T; Jiang C; Liang P Stem Cell Res Ther; 2023 Sep; 14(1):241. PubMed ID: 37679791 [TBL] [Abstract][Full Text] [Related]
9. Switch From Fetal to Adult Veerman CC; Mengarelli I; Lodder EM; Kosmidis G; Bellin M; Zhang M; Dittmann S; Guan K; Wilde AAM; Schulze-Bahr E; Greber B; Bezzina CR; Verkerk AO J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28739862 [TBL] [Abstract][Full Text] [Related]
10. A Preclinical Study on Brugada Syndrome with a CACNB2 Variant Using Human Cardiomyocytes from Induced Pluripotent Stem Cells. Zhong R; Schimanski T; Zhang F; Lan H; Hohn A; Xu Q; Huang M; Liao Z; Qiao L; Yang Z; Li Y; Zhao Z; Li X; Rose L; Albers S; Maywald L; Müller J; Dinkel H; Saguner A; Janssen JWG; Swamy N; Xi Y; Lang S; Kleinsorge M; Duru F; Zhou X; Diecke S; Cyganek L; Akin I; El-Battrawy I Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955449 [TBL] [Abstract][Full Text] [Related]
11. Biophysical comparison of sodium currents in native cardiac myocytes and human induced pluripotent stem cell-derived cardiomyocytes. Goodrow RJ; Desai S; Treat JA; Panama BK; Desai M; Nesterenko VV; Cordeiro JM J Pharmacol Toxicol Methods; 2018; 90():19-30. PubMed ID: 29128504 [TBL] [Abstract][Full Text] [Related]
12. Novel insights in the pathomechanism of Brugada syndrome and fever-related type 1 ECG changes in a preclinical study using human-induced pluripotent stem cell-derived cardiomyocytes. Li Y; Dinkel H; Pakalniskyte D; Busley AV; Cyganek L; Zhong R; Zhang F; Xu Q; Maywald L; Aweimer A; Huang M; Liao Z; Meng Z; Yan C; Prädel T; Rose L; Moscu-Gregor A; Hohn A; Yang Z; Qiao L; Mügge A; Zhou X; Akin I; El-Battrawy I Clin Transl Med; 2023 Mar; 13(3):e1130. PubMed ID: 36881552 [TBL] [Abstract][Full Text] [Related]
13. De Novo Mutation in the SCN5A Gene Associated with Brugada Syndrome. Wang L; Meng X; Yuchi Z; Zhao Z; Xu D; Fedida D; Wang Z; Huang C Cell Physiol Biochem; 2015; 36(6):2250-62. PubMed ID: 26279430 [TBL] [Abstract][Full Text] [Related]
14. GPD1L-A306del modifies sodium current in a family carrying the dysfunctional SCN5A-G1661R mutation associated with Brugada syndrome. Semino F; Darche FF; Bruehl C; Koenen M; Skladny H; Katus HA; Frey N; Draguhn A; Schweizer PA Pflugers Arch; 2024 Feb; 476(2):229-242. PubMed ID: 38036776 [TBL] [Abstract][Full Text] [Related]
15. Ajmaline blocks I Miller DC; Harmer SC; Poliandri A; Nobles M; Edwards EC; Ware JS; Sharp TV; McKay TR; Dunkel L; Lambiase PD; Tinker A Stem Cell Res; 2017 Dec; 25():233-244. PubMed ID: 29172153 [TBL] [Abstract][Full Text] [Related]
16. Development of a Patient-Derived Induced Pluripotent Stem Cell Model for the Investigation of SCN5A-D1275N-Related Cardiac Sodium Channelopathy. Hayano M; Makiyama T; Kamakura T; Watanabe H; Sasaki K; Funakoshi S; Wuriyanghai Y; Nishiuchi S; Harita T; Yamamoto Y; Kohjitani H; Hirose S; Yokoi F; Chen J; Baba O; Horie T; Chonabayashi K; Ohno S; Toyoda F; Yoshida Y; Ono K; Horie M; Kimura T Circ J; 2017 Nov; 81(12):1783-1791. PubMed ID: 28637969 [TBL] [Abstract][Full Text] [Related]
17. Readthrough-Promoting Drugs Gentamicin and PTC124 Fail to Rescue Nav1.5 Function of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Carrying Nonsense Mutations in the Sodium Channel Gene SCN5A. Kosmidis G; Veerman CC; Casini S; Verkerk AO; van de Pas S; Bellin M; Wilde AA; Mummery CL; Bezzina CR Circ Arrhythm Electrophysiol; 2016 Nov; 9(11):. PubMed ID: 27784737 [TBL] [Abstract][Full Text] [Related]
18. Sodium channel current loss of function in induced pluripotent stem cell-derived cardiomyocytes from a Brugada syndrome patient. Selga E; Sendfeld F; Martinez-Moreno R; Medine CN; Tura-Ceide O; Wilmut SI; Pérez GJ; Scornik FS; Brugada R; Mills NL J Mol Cell Cardiol; 2018 Jan; 114():10-19. PubMed ID: 29024690 [TBL] [Abstract][Full Text] [Related]
19. SCN5A(K817E), a novel Brugada syndrome-associated mutation that alters the activation gating of NaV1.5 channel. Kinoshita K; Takahashi H; Hata Y; Nishide K; Kato M; Fujita H; Yoshida S; Murai K; Mizumaki K; Nishida K; Yamaguchi Y; Kano M; Tabata T; Nishida N Heart Rhythm; 2016 May; 13(5):1113-1120. PubMed ID: 26776555 [TBL] [Abstract][Full Text] [Related]
20. Identification of an I Ma D; Liu Z; Loh LJ; Zhao Y; Li G; Liew R; Islam O; Wu J; Chung YY; Teo WS; Ching CK; Tan BY; Chong D; Ho KL; Lim P; Yong RYY; Panama BK; Kaplan AD; Bett GCL; Ware J; Bezzina CR; Verkerk AO; Cook SA; Rasmusson RL; Wei H Sci Rep; 2018 Jul; 8(1):11246. PubMed ID: 30050137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]